MicroRNA-21 (miR-21), Mutant Tumor Protein p53, and Matrix Metalloproteinase-9 (MMP-9) as Risk Markers for High-Grade Tumor Budding (HGTB) in Cervical Carcinoma: A Case-Control Study in a Balinese Population.

Abstract excerpt

OBJECTIVE: High-grade tumor budding (HGTB) is still a controversial parameter in determining the aggressiveness of cervical carcinoma, yet the molecular mechanism of TB is still not comprehensively understood. This study aimed to evaluate whether miR-21, mutant p53, and MMP-9 expression are associated with HGTB in cervical carcinoma. METHODS: This nested case-control study was conducted at the Anatomical...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biomarkers, Tumor
• Share to Follow-Up Studies
• Share to Matrix Metalloproteinase 9